You are here

drug pricing

Pfizer CEO Bourla asks employees to join the scrum for D.C. drug-pricing fight

Fierce Pharma

Thu, 09/23/21 - 11:03 am

CEOs of AbbVie, BMS, Lilly, GSK and more raise concerns about Washington's intensifying drug-pricing push

Fierce Pharma

Thu, 09/16/21 - 10:50 am

Bristol Myers Squibb

Moderate Democrats sink Pelosi’s aggressive drug pricing bill in key committee vote

Stat

Wed, 09/15/21 - 10:24 pm

House moderates rebel against Pelosi drug pricing plan, leaving bill’s fate uncertain

Stat

Tue, 09/14/21 - 10:37 pm

Novo Nordisk, Roche see outsized threats from U.S. drug pricing talks: analysts

Fierce Pharma

Mon, 09/13/21 - 10:41 am

Martin Shkreli to go toe-to-toe with new FTC chair over Daraprim price spikes

Endpoints

Fri, 09/10/21 - 10:58 am

New Biden plan to lower drug prices drawn from familiar Democratic playbook

Stat

Thu, 09/9/21 - 11:21 pm

Merck, Amgen adopt double-digit price hikes in test to Big Pharma's unofficial annual limits: analyst

Fierce Pharma

Wed, 09/1/21 - 11:23 am

With drug pricing reform potentially closer than ever, Public Citizen pens new letter calling for change

Endpoints

Wed, 09/1/21 - 11:08 am

CBO: Proposed Medicare pricing plan could curb drug development

RAPS.org

Mon, 08/30/21 - 11:20 pm

drug development

CBO warns of almost 60 fewer new drugs over three decades with Medicare drug negotiations bill

Endpoints

Thu, 08/26/21 - 08:49 pm

‘It’s not really price transparency’: Pharmacies push back on Surescripts, GoodRx deal

MedCity News

Sun, 08/22/21 - 09:44 pm

House committee questions Eli Lilly, Sanofi and Novo Nordisk as insulin prices remain 'unacceptably high'

Endpoints

Fri, 08/20/21 - 12:31 pm

Dueling 7-figure ad campaigns set sights on a big drug price negotiation bill coming soon

Endpoints

Tue, 08/17/21 - 10:11 am

patient advocacy groups

As Biden signals interest in linking drug prices with R&D costs, new study finds costs per NME are increasing

Endpoints

Mon, 08/16/21 - 12:03 pm

drug development

J&J, Amgen and Roche face growing biosimilar competition that is driving down prices: report

Fierce Pharma

Thu, 08/12/21 - 11:04 pm

In a new policy proposal, Biden presses Congress to let Medicare negotiate drug prices

Stat

Thu, 08/12/21 - 11:16 am

CMS proposes to Withdraw Trump Era Most Favored Nation (MFN) Drug Pricing Rule

FDA Law Blog

Tue, 08/10/21 - 11:13 pm

Medicare Part B

most favored nation

More brand-name drug prices hiked this year than in all of 2020, study finds

Beckers Hospital Review

Wed, 07/28/21 - 11:31 pm

AstraZeneca's newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says

Fierce Pharma

Sun, 07/25/21 - 11:44 am

myasthenia gravis

Pages